Institutional members access full text with Ovid®

Share this article on:

Long-Term Safety and Efficacy of a Unique Fixed-Dose Combination Gel of Adapalene 0.1% and Benzoyl Peroxide 2.5% for the Treatment of Acne Vulgaris

Pariser, David M. MD MD1; Westmoreland, Patricia MD2; Morris, Amy MD3; Gold, Michael H. MD4; Liu, Yin MD5; Graeber, Michael MD5On Behalf of the Adapalene BPO Study Group

Journal of the Dermatology Nurses' Association: March-April 2009 - Volume 1 - Issue 2 - p 146
doi: 10.1097/01.JDN.0000350427.23616.3b
DEPARTMENTS: 2009 Conference Abstracts

1 Virginia Clinical Research, Inc, and Eastern Virginia Medical School, Norfolk, VA 2 Palmetto Clinical Trial Services, LLC, Simpsonville, SC 3 Coastal Clinical Research, Inc, Mobile, AL 4 Tennessee Clinical Research Center, Nashville, TN 5 Galderma Research & Development, Princeton, NJ

© 2009 Lippincott Williams & Wilkins, Inc.